Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$38.68M
110.04K shares
TAUB REBECCA plans to sell 110.04K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $38.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2025 | Exercise of Stock Options Cash | 43.26K | — |
| Total | 43.26K | ||
Completed
Units to sell
3.20K
Market value
$1.12M
Units to sell
3.20K
Market value
$1.12M
Units to sell
1.40K
Market value
$490.0K
Units to sell
1K
Market value
$350.0K
Units to sell
2.70K
Market value
$946.3K
Units to sell
2.66K
Market value
$931.0K
Units to sell
26.18K
Market value
$9.25M
Units to sell
26.44K
Market value
$9.35M
Planned — Approximate Date
Units to sell
43.26K
Market value
$15.12M
Units
110.04K
Value
$38.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/11/2025 | 3.20K | $1.12M | — | Completed |
8/11/2025 | 3.20K | $1.12M | — | Completed |
7/18/2025 | 1.40K | $490.0K | — | Completed |
7/18/2025 | 1K | $350.0K | — | Completed |
7/17/2025 | 2.70K | $946.3K | — | Completed |
7/17/2025 | 2.66K | $931.0K | — | Completed |
7/16/2025 | 26.18K | $9.25M | — | Completed |
7/16/2025 | 26.44K | $9.35M | — | Completed |
| Planned — Approximate Date | ||||
8/12/2025 | 43.26K | $15.12M | NASDAQ | Planned |
| Total | 110.04K | $38.68M | ||